Squarepoint’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $450K | Sell |
30,046
-41,965
| -58% | -$628K | ﹤0.01% | 1965 |
|
|
2025
Q1 | $1.16M | Buy |
72,011
+56,780
| +373% | +$916K | ﹤0.01% | 1426 |
|
|
2024
Q4 | $355K | Buy |
15,231
+6,754
| +80% | +$157K | ﹤0.01% | 2114 |
|
|
2024
Q3 | $249K | Buy |
+8,477
| New | +$249K | ﹤0.01% | 2087 |
|
|
2024
Q2 | – | Sell |
-8,161
| Closed | -$310K | – | 2962 |
|
|
2024
Q1 | $310K | Buy |
+8,161
| New | +$310K | ﹤0.01% | 1900 |
|
|
2020
Q4 | – | Sell |
-1,608
| Closed | -$285K | – | 2867 |
|
|
2020
Q3 | $285K | Buy |
1,608
+56
| +4% | +$9.93K | ﹤0.01% | 1710 |
|
|
2020
Q2 | $359K | Buy |
1,552
+601
| +63% | +$139K | 0.01% | 1465 |
|
|
2020
Q1 | $111K | Sell |
951
-978
| -51% | -$114K | ﹤0.01% | 1613 |
|
|
2019
Q4 | $368K | Sell |
1,929
-905
| -32% | -$173K | ﹤0.01% | 1875 |
|
|
2019
Q3 | $545K | Buy |
2,834
+719
| +34% | +$138K | ﹤0.01% | 1522 |
|
|
2019
Q2 | $362K | Buy |
2,115
+565
| +36% | +$96.7K | ﹤0.01% | 1794 |
|
|
2019
Q1 | $312K | Sell |
1,550
-828
| -35% | -$167K | ﹤0.01% | 1708 |
|
|
2018
Q4 | $445K | Sell |
2,378
-482
| -17% | -$90.2K | 0.01% | 1298 |
|
|
2018
Q3 | $684K | Buy |
2,860
+1,536
| +116% | +$367K | 0.01% | 1164 |
|
|
2018
Q2 | $350K | Buy |
1,324
+900
| +212% | +$238K | ﹤0.01% | 1323 |
|
|
2018
Q1 | $105K | Buy |
+424
| New | +$105K | ﹤0.01% | 1561 |
|
|
2017
Q2 | – | Sell |
-488
| Closed | -$91K | – | 1790 |
|
|
2017
Q1 | $91K | Buy |
+488
| New | +$91K | ﹤0.01% | 1415 |
|